Nucleoside inhibitors of tick-borne encephalitis virus

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 9, 2015, Pages 5483-5493

  Eyer, Luděk ^a   Valdés, James J ^b   Gil, Victor A ^c   Nencka, Radim ^d   Hřebabecký, Hubert ^d   Šála, Michal ^d   Salát, Jiří ^a   Černý, Jiří ^a,b,e   Palus, Martin ^a,b,e   De Clercq, Erik ^f   Růžek, Daniel ^a,b,e  

^a VETERINARY RESEARCH INSTITUTE   (Czech Republic)

^b INSTITUTE OF PARASITOLOGY   (Czech Republic)

^c INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^d INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^e UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^f REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2' C METHYLADENOSINE; 2' METHYLCYTIDINE; 7 DEAZA 2' C METHYLADENOSINE; ANTIVIRUS AGENT; NUCLEOSIDE ANALOG; UNCLASSIFIED DRUG; VIRUS ANTIGEN; 2'-C-METHYLADENOSINE; 2'-C-METHYLCYTIDINE; 7-DEAZA-2'-C-METHYLADENOSINE; ADENOSINE; CYTIDINE; NUCLEOSIDE; TUBERCIDIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CYTOPATHOGENIC EFFECT; CYTOTOXIC CONCENTRATION; CYTOTOXICITY ASSAY; DOSE RESPONSE; DRUG STRUCTURE; EFFECTIVE CONCENTRATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; KIDNEY CELL; NEUROBLASTOMA CELL; NONHUMAN; PIG; PRIORITY JOURNAL; TICK BORNE ENCEPHALITIS VIRUS; VIRUS ENCEPHALITIS; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN; ANALOGS AND DERIVATIVES; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECTS;

ADENOSINE; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CYTIDINE; ENCEPHALITIS VIRUSES, TICK-BORNE; HUMANS; NUCLEOSIDES; SWINE; TUBERCIDIN; VIRUS REPLICATION;

EID: 84940952926     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00807-15     Document Type: Article

References (56)

1. Baier A. 2011. Flaviviral infections and potential targets for antiviral therapy, p 89-104. In Ruzek D (ed), Flavivirus encephalitis. InTech, Rijeka, Croatia.
2. Chambers TJ, Hahn CS, Galler R, Rice CM 1990. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44:649-688. http://dx.doi.org/10.1146/annurev.mi.44.100190.003245.
3. Dumpis U, Crook D, Oksi J. 1999. Tick-borne encephalitis. Clin Infect Dis 28:882-890. http://dx.doi.org/10.1086/515195.
4. Heinz FX, Mandl CW 1993. The molecular biology of tick-borne encephalitis virus. APMIS 101:735-745. http://dx.doi.org/10.1111/j.1699-0463.1993.tb00174.x.
5. Heinz FX, Stiasny K, Holzmann H, Grgic-Vitek M, Kriz B, Essl A, Kundi M. 2013. Vaccination and tick-borne encephalitis, Central Europe. Emerg Infect Dis 19:69-76. http://dx.doi.org/10.3201/eid1901.120458.
6. Ruzek D, Dobler G, Mantke OD 2010. Tick-borne encephalitis: pathogenesis and clinical implications. Travel Med Infect Dis 8:223-232. http://dx.doi.org/10.1016/j.tmaid.2010.06.004.
7. Zavadska D, Anca I, Andre F, Bakir M, Chlibek R, Cizman M, Ivaskeviciene I, Mangarov A, Meszner Z, Pokorn M, Prymula R, Richter D, Salman N, Simurka P, Tamm E, Tesovic G, Urbancikova I, Usonis V. 2013. Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG). Hum Vaccin Immunother 9:362-374. http://dx.doi.org/10.4161/hv.22766.
8. Puig-Basagoiti F, Tilgner M, Forshey BM, Philpott SM, Espina NG, Wentworth DE, Goebel SJ, Masters PS, Falgout B, Ren P, Ferguson DM, Shi PY. 2006. Triaryl pyrazoline compound inhibits flavivirus RNA replication. Antimicrob Agents Chemother 50:1320-1329. http://dx.doi.org/10.1128/AAC.50.4.1320-1329.2006.
9. De Clercq E, Neyts J. 2009. Antiviral agents acting as DNA or RNA chain terminators. Handb Exp Pharmacol 189:53-84. http://dx.doi.org/10.1007/978-3-540-79086-0-3.
10. De Clercq E. 2004. Antivirals and antiviral strategies. Nat Rev Microbiol 2:704-720. http://dx.doi.org/10.1038/nrmicro975.
11. De Clercq E. 2011. A 40-year journey in search of selective antiviral chemotherapy. Annu Rev Pharmacol Toxicol 51:1-24. http://dx.doi.org/10.1146/annurev-pharmtox-010510-100228.
12. Eldrup AB, Allerson CR, Bennett CF, Bera S, Bhat B, Bhat N, Bosserman MR, Brooks J, Burlein C, Carroll SS, Cook PD, Getty KL, MacCoss M, McMasters DR, Olsen DB, Prakash TP, Prhavc M, Song QL, Tomassini JE, Xia J. 2004. Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase. J Med Chem 47:2283-2295. http://dx.doi.org/10.1021/jm030424e.
13. Migliaccio G, Tomassini JE, Carroll SS, Tomei L, Altamura S, Bhat B, Bartholomew L, Bosserman MR, Ceccacci A, Colwell LF, Cortese R, De Francesco R, Eldrup AB, Getty KL, Hou XS, LaFemina RL, Ludmerer SW, MacCoss M, McMasters DR, Stahlhut MW, Olsen DB, Hazuda DJ, Flores OA. 2003. Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro. J Biol Chem 278:49164-49170. http://dx.doi.org/10.1074/jbc.M305041200.
14. Olsen DB, Eldrup AB, Bartholomew L, Bhat B, Bosserman MR, Ceccacci A, Colwell LF, Fay JF, Flores OA, Getty KL, Grobler JA, LaFemina RL, Markel EJ, Migliaccio G, Prhavc M, Stahlhut MW, Tomassini JE, MacCoss M, Hazuda DJ, Carroll SS. 2004. A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties. Antimicrob Agents Chemother 48: 3944-3953. http://dx.doi.org/10.1128/AAC.48.10.3944-3953.2004.
15. Klumpp K, Leveque V, Le Pogam S, Ma H, Jiang WR, Kang HS, Granycome C, Singer M, Laxton C, Hang JQ, Sarma K, Smith DB, Heindl D, Hobbs CJ, Merrett JH, Symons J, Cammack N, Martin JA, Devos R, Najera I. 2006. The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture. J Biol Chem 281:3793-3799. http://dx.doi.org/10.1074/jbc.M510195200.
16. Klumpp K, Kalayanov G, Ma H, Le Pogam S, Leveque V, Jiang WR, Inocencio N, De Witte A, Rajyaguru S, Tai E, Chanda S, Irwin MR, Sund C, Winqist A, Maltseva T, Eriksson S, Usova E, Smith M, Alker A, Najera I, Cammack N, Martin JA, Johansson NG, Smith DB. 2008. 2'-Deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups. J Biol Chem 283:2167-2175. http://dx.doi.org/10.1074/jbc.M708929200.
17. Yin Z, Chen YL, Schul W, Wang QY, Gu F, Duraiswamy J, Kondreddi RR, Niyomrattanakit P, Lakshminarayana SB, Goh A, Xu HY, Liu W, Liu B, Lim JY, Ng CY, Qing M, Lim CC, Yip A, Wang G, Chan WL; Tan HP, Lin K, Zhang B, Zou G, Bernard KA, Garrett C, Beltz K, Dong M, Weaver M, He H, Pichota A, Dartois V, Keller Thomas H, Shi PY. 2009. An adenosine nucleoside inhibitor of dengue virus. Proc Natl Acad Sci U S A 106:20435-20439. http://dx.doi.org/10.1073/pnas.0907010106.
18. Chen YL, Yin Z, Duraiswamy J, Schul W, Lim CC, Liu B, Xu HY, Qing M, Yip A, Wang G, Chan WL, Tan HP, Lo M, Liung S, Kondreddi RR, Rao R, Gu H, He H, Keller TH, Shi PY. 2010. Inhibition of dengue virus RNA synthesis by an adenosine nucleoside. Antimicrob Agents Chemother 54:2932-2939. http://dx.doi.org/10.1128/AAC.00140-10.
19. Chen YL, Yin Z, Lakshminarayana SB, Qing M, Schul W, Duraiswamy J, Kondreddi RR, Goh A, Xu HY, Yip A, Liu B, Weaver M, Dartois V, Keller TH, Shi PY. 2010. Inhibition of dengue virus by an ester prodrug of an adenosine analog. Antimicrob Agents Chemother 54:3255-3261. http://dx.doi.org/10.1128/AAC.00397-10.
20. Latour DR, Jekle A, Javanbakht H, Henningsen R, Gee P, Lee I, Tran P, Ren S, Kutach AK, Harris SF, Wang SM, Lok SJ, Shaw D, Li J, Heilek G, Klumpp K, Swinney DC, Deval J. 2010. Biochemical characterization of the inhibition of the dengue virus RNA polymerase by beta-D-2'-ethynyl-7-deaza-adenosine triphosphate. Antiviral Res 87:213-222. http://dx.doi.org/10.1016/j.antiviral.2010.05.003.
21. Lee JC, Tseng CK, Wu YH, Kaushik-Basu N, Lin CK, Chen WC, Wu HN 2015. Characterization of the activity of 2'-C-methylcytidine against dengue virus replication. Antiviral Res 116:1-9. http://dx.doi.org/10.1016/j.antiviral.2015.01.002.
22. Chen H, Liu L, Jones SA, Banavali N, Kass J, Li Z, Zhang J, Kramer LD, Ghosh AK, Li H. 2013. Selective inhibition of the West Nile virus methyltransferase by nucleoside analogs. Antiviral Res 97:232-239. http://dx.doi.org/10.1016/j.antiviral.2012.12.012.
23. Julander JG, Jha AK, Choi JA, Jung KH, Smee DF, Morrey JD, Chu CK 2010. Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster model. Antiviral Res 86:261-267. http://dx.doi.org/10.1016/j.antiviral.2010.03.004.
24. Smee DF, Morris JLB, Barnard DL, Vanaerschot A. 1992. Selective inhibition of arthropod-borne and arenaviruses in vitro by 3'-fluoro-3'-deoxyadenosine. Antiviral Res 18:151-162. http://dx.doi.org/10.1016/0166-3542(92)90035-4.
25. Smee DF, Alaghamandan HA, Ramasamy K, Revankar GR 1995. Broad-spectrum activity of 8-chloro-7-deazaguanosine against RNA virus infections in mice and rats. Antiviral Res 26:203-209. http://dx.doi.org/10.1016/0166-3542(94)00084-L.
26. Ojwang JO, Ali S, Smee DF, Morrey JD, Shimasaki CD, Sidwell RW 2005. Broad-spectrum inhibitor of viruses in the Flaviviridae family. Antiviral Res 68:49-55. http://dx.doi.org/10.1016/j.antiviral.2005.06.002.
27. Chatelain G, Debing Y, De Burghgraeve T, Zmurko J, Saudi M, Rozenski J, Neyts J, Van Aerschot A. 2013. In search of flavivirus inhibitors: evaluation of different tritylated nucleoside analogues. Eur J Med Chem 65:249-255. http://dx.doi.org/10.1016/j.ejmech.2013.04.034.
28. Koonin EV, Dolja VV 1993. Evolution and taxonomy of positive-strand RNA viruses-implications of comparative analysis of amino acid sequences. Crit Rev Biochem Mol Biol 28:375-430. http://dx.doi.org/10.3109/10409239309078440.
29. Flint M, McMullan LK, Dodd KA, Dodd KA, Bird BH, Khristova ML, Nichol ST, Spiropoulou CF 2014. Inhibitors of the tick-borne, hemorrhagic fever-associated flaviviruses. Antimicrob Agents Chemother 58: 3206-3216. http://dx.doi.org/10.1128/AAC.02393-14.
30. Kozuch O, Mayer V. 1975. Pig kidney epithelial (ps) cells-perfect tool for study of flavi-viruses and some other arboviruses. Acta Virol 19:498.
31. Růzek D, Vancova M, Tesarova M, Ahantarig A, Kopecky J, Grubhoffer L. 2009. Morphological changes in human neural cells following tickborne encephalitis virus infection. J Gen Virol 90:1649-1658. http://dx.doi.org/10.1099/vir.0.010058-0.
32. De Madrid AT, Porterfield JS 1969. A simple micro-culture method for study of group B arboviruses. Bull World Health Organ 40:113-121.
33. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. 2012. Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676-682. http://dx.doi.org/10.1038/nmeth.2019.
34. Sali A, Blundell TL 1993. Comparative protein modeling by satisfaction of spatial restraints. J Mol Biol 234:779-815. http://dx.doi.org/10.1006/jmbi.1993.1626.
35. McGuffin LJ, Buenavista MT, Roche DB 2013. The ModFOLD4 server for the quality assessment of 3D protein models. Nucleic Acids Res 41: W368-W372. http://dx.doi.org/10.1093/nar/gkt294.
36. Benkert P, Kuenzli M, Schwede T. 2009. QMEAN server for protein model quality estimation. Nucleic Acids Res 37:W510-W514. http://dx.doi.org/10.1093/nar/gkp322.
37. Berjanskii M, Zhou J, Liang Y, Lin G, Wishart DS 2012. Resolutionby-proxy: a simple measure for assessing and comparing the overall quality of NMR protein structures. J Biomol NMR 53:167-180. http://dx.doi.org/10.1007/s10858-012-9637-2.
38. Li X, Jacobson MP, Zhu K, Zhao S, Friesner RA 2007. Assignment of polar states for protein amino acid residues using an interaction cluster decomposition algorithm and its application to high resolution protein structure modeling. Proteins 66:824-837.
39. Schrödinger LLC. 2010. Maestro version 9.1. Schrödinger LLC, New York, NY.
40. Madadkar-Sobhani A, Guallar V. 2013. PELE web server: atomistic study of biomolecular systems at your fingertips. Nucleic Acids Res 41:W322-W328. http://dx.doi.org/10.1093/nar/gkt454.
41. Takhampunya R, Ubol S, Houng HS, Cameron CE, Padmanabhan R. 2006. Inhibition of dengue virus replication by mycophenolic acid and ribavirin. J Gen Virol 87:1947-1952. http://dx.doi.org/10.1099/vir.0.81655-0.
42. Atilgan AR, Durell SR, Jernigan RL, Demirel MC, Keskin O, Bahar I. 2001. Anisotropy of fluctuation dynamics of proteins with an elastic network model. Biophys J 80:505-515. http://dx.doi.org/10.1016/S0006-3495(01)76033-X.
43. Jacobson MP, Friesner RA, Xiang ZX, Honig B. 2002. On the role of the crystal environment in determining protein side-chain conformations. J Mol Biol 320:597-608. http://dx.doi.org/10.1016/S0022-2836(02)00470-9.
44. Still WC, Tempczyk A, Hawley RC, Hendrickson T. 1990. Semianalytical treatment of solvation for molecular mechanics and dynamics. J Am Chem Soc 112:6127-6129. http://dx.doi.org/10.1021/ja00172a038.
45. Borrelli KW, Vitalis A, Alcantara R, Guallar V. 2005. PELE: protein energy landscape exploration. A novel Monte Carlo based technique. J Chem Theory Comput 1:1304-1311.
46. Jorgensen WL, Tiradorives J. 1988. The Opls potential functions for proteins-energy minimizations for crystals of cyclic peptides and crambin. J Am Chem Soc 110:1657-1666. http://dx.doi.org/10.1021/ja00214a001.
47. Gil VA, Guallar V. 2014. pyProCT: automated cluster analysis for structural bioinformatics. J Chem Theory Comput 10:3236-3243. http://dx.doi.org/10.1021/ct500306s.
48. Osolodkin DI, Kozlovskaya LI, Dueva EV, Dotsenko VV, Rogova YV, Frolov KA, Krivokolysko SG, Romanova EG, Morozov AS, Karganova GG, Palyulin VA, Pentkovski VM, Zefirov NS. 2013. Inhibitors of tick-borne flavivirus reproduction from structure-based virtual screening. ACS Med Chem Lett 4:869-874. http://dx.doi.org/10.1021/ml400226s.
49. Wallner G, Mandl CW, Ecker M, Holzmann H, Stiasny K, Kunz C, Heinz FX 1996. Characterisation and complete genome sequences of high- and low-virulence variants of tick-borne encephalitis virus. J Gen Virol 77:1035-1042. http://dx.doi.org/10.1099/0022-1317-77-5-1035.
50. Crance JM, Scaramozzino N, Jouan A, Garin D. 2003. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res 58:73-79. http://dx.doi.org/10.1016/S0166-3542(02)00185-7.
51. Carroll SS, Tomassini JE, Bosserman M, Getty K, Stahlhut MW, Eldrup AB, Bhat B, Hall D, Simcoe AL, LaFemina R, Rutkowski CA, Wolanski B, Yang ZC, Migliaccio G, De Francesco R, Kuo LC, MacCoss M, Olsen DB. 2003. Inhibition of hepatitis C virus RNA replication by 2'modified nucleoside analogs. J Biol Chem 278:11979-11984. http://dx.doi.org/10.1074/jbc.M210914200.
52. Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, Camaioni E. 2001. Adenosine deaminase: functional implications and different classes of inhibitors. Med Res Rev 21:105-128. http://dx.doi.org/10.1002/1098-1128(200103)21:2<105::AID-MED1002>3.0.CO;2-U.
53. Kinney RM, Huang CYH, Rose BC, Kroeker AD, Dreher TW, Iversen PL, Stein DA 2005. Inhibition of dengue virus serotypes 1 to 4 in Vero cell cultures with morpholino oligomers. J Virol 79:5116-5128. http://dx.doi.org/10.1128/JVI.79.8.5116-5128.2005.
54. Carroll SS, Ludmerer S, Handt L, Koeplinger K, Zhang NR, Graham D, Davies ME, MacCoss M, Hazuda D, Olsen DB 2009. Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzees. Antimicrob Agents Chemother 53:926-934. http://dx.doi.org/10.1128/AAC.01032-08.
55. Carroll SS, Koeplinger K, Vavrek M, Zhang NR, Handt L, MacCoss M, Olsen DB, Reddy KR, Sun ZL, van Poelje PD, Fujitaki JM, Boyer SH, Linemeyer DL, Hecker SJ, Erion MD. 2011. Antiviral efficacy upon administration of a HepDirect prodrug of 2'-c-methylcytidine to hepatitis C virus-infected chimpanzees. Antimicrob Agents Chemother 55:3854-3860. http://dx.doi.org/10.1128/AAC.01152-10.
56. Sofia MJ, Chang W, Furman PA, Mosley RT, Ross BS 2012. Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase. J Med Chem 55:2481-2531. http://dx.doi.org/10.1021/jm201384j.